Over 450 Total Lots Up For Auction at Three Locations - CO 05/12, PA 05/15, NY 05/20

Kromek inks new and revised deals totaling $3.1 million

Press releases may be edited for formatting or style | October 18, 2016 Risk Management X-Ray
customers. The contract wins add to the visibility of revenues underpinning our belief in the continuing
growth of the business and commercial traction resulting from the increasing adoption of CZT-based
technology.”

About Kromek Group plc
stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats

Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer
of high performance radiation detection products based on cadmium zinc telluride (“CZT”). Using its
core CZT technology, Kromek designs develops and produces x-ray and gamma ray imaging and radiation
detection products for the medical, security screening and nuclear markets.

The Group’s products provide high resolution information on material composition and structure and are
used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials,
such as explosives, and the analysis of radioactive materials.

The Group’s business model provides a vertically integrated technology offering to customers, from the
growth of CZT crystals to finished products or detectors, including software, electronics and application
specific integrated circuits (“ASICs”).

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally
through a combination of distributors and direct OEM sales.

Currently, the Group has over a hundred full time employees across its global operations. Further
information on Kromek Group is available at www.kromek.com.

Back to HCB News

You Must Be Logged In To Post A Comment